Page last updated: 2024-08-23

idarubicin and Conjunctival Neoplasms

idarubicin has been researched along with Conjunctival Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alexander, C; Bashford, J; Jefferies, PD; Lee, GA; Whitehead, K1
Douglas, RS; Goldstein, SM; Nichols, C1

Other Studies

2 other study(ies) available for idarubicin and Conjunctival Neoplasms

ArticleYear
Life-threatening conjunctival presentation of myeloid sarcoma.
    Clinical & experimental ophthalmology, 2008, Volume: 36, Issue:8

    Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Conjunctival Neoplasms; Cytarabine; Etoposide; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Middle Aged; Neoplasms, Second Primary; Sarcoma, Myeloid; Skin Neoplasms

2008
Acute myelogenous leukaemia presenting as a conjunctival lesion and red eye.
    Acta ophthalmologica Scandinavica, 2002, Volume: 80, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Conjunctiva; Conjunctival Neoplasms; Cytarabine; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute

2002